On Thursday, Georgia Governor Brian Kemp announced that Gerresheimer, a manufacturer for the pharma and life science industry, would be opening a new facility in Peachtree City, investing more than $88 million and creating over 200 new jobs.
“This project is a prime example of the exciting growth of the life sciences industry in our state, with companies like Gerresheimer bringing career opportunities to all four corners of Georgia” said Kemp. “Employers from across the globe can find a skilled workforce here that we are continuously investing in through innovative programs like the GEORGIA MATCH Direct College Admissions Initiative. We’re excited to see how this expansion will further benefit the community and surrounding region.”
According to a press release from Kemp’s office, “Germany-based Gerresheimer offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems, and medical devices as well as solutions for the health and cosmetics industry. Gerresheimer currently supports more than 260 jobs in Peachtree City. The existing Gerresheimer manufacturing facility is already in the midst of an expansion, where it will support an additional 180 jobs with operations beginning in April 2024. Today’s announcement marks yet another investment by the company here in the No. 1 state for business.”
“We appreciate the continuous support of the State of Georgia for our expansion in the U.S.,” said Dietmar Siemssen, CEO of Gerresheimer AG. “The U.S. market is an important growth driver for us, and the expansion of our operations in Peachtree City will be key for growing our medical device business in the U.S. We are glad that we have found such favorable conditions and a highly motivated and skilled staff here.”
Georgia outpaces the nation in life sciences employment, with a 20 percent growth rate since 2015, the press release said. The industry currently supports more than 78,000 jobs statewide, and more than 4,000 life science organizations operate in Georgia.